Notice of Effectiveness (effect)
November 21 2022 - 6:03AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | November 18,
2022 |
---|
Form: | S-3 |
---|
CIK: | 0001840233 |
---|
Company Name: | Xilio Therapeutics, Inc. |
---|
File Number: | 333-268264 |
---|
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From Apr 2023 to Apr 2024